返回 Agenda
SESSION 3 : New Era for Product Information in Digital Health and Pharmacovigilance
Session Chair(s)
Shun Jin, MBA
Head – BD & RA
PharmaGend Global Medical Services Pte Ltd, Singapore
Rie Matsui, RPH
Senior Director, Regional Labeling Head for APAC
Pfizer R&D Japan G.K., Japan
Speaker(s)
New Era for Product Information in Digital Health and Pharmacovigilance: FHIR and Electronic Product Information (ePI)
Craig Anderson
Pfizer, Canada
Director, Data Standards & Continuous Improvement
Gravitate – Health ePI on FHIR in EU and beyond
Anne Moen, PHD, MSC, RN
University of Oslo, Norway
Professor, Faculty of Medicine, Coordinator, Gravitate-Health
Current and Future e-labeling in Japan ~Considering Interoperability (HL7 FHIR) from a Health Care Professional Perspective ~
Yoshihiro Aoyagi, MS
National Cancer Center Hospital East, Japan
Manager, Department of Medical Information
Digital health and product information in Japan
Arisa Toyoda
Ministry of Health, Labour and Welfare, Japan
Pharmaceutical Safety Division, Pharmaceutical Safety
Updates for Pharmacovigilance initiatives in China
Yuan Meng
I-Mab Biopharma , China
Head of Medical Office R&D